You are about to leave Helsinn's Corporate US Website.

Please click 'Continue to external site' if you want to continue.

Cancer Therapeutics

Helsinn is expanding its portfolio of cancer therapeutics to address an unmet patient need in this area.  Based on our extensive experience in cancer care and our comprehensive understanding of cancer patients and their journey, we believe that we bring a unique perspective to addressing this unmet need.